- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03036345
Cerebral Perfusion in the Beach Chair Position
Prediction of Post-operative Cognitive Decline Following Shoulder Surgery in the Beach Chair Position: The Value of Cerebral Oximetry
Surgery to the shoulder may be performed with patients seated upright in a position known as the "Beach Chair Position (BCP)." This position has certain advantages compared to alternative surgical positions (e.g. side lying) in some situations. However, it has been found that surgery in the BCP can temporarily decrease the amount of oxygen in the brain as a result of the combined effects of gravity and anaesthesia. This can result in complications following surgery such as some memory loss and confusion. Rarely, more serious complications have been reported in the past including death and stroke.
Due to these reported complications the use of "cerebral oximetry" during shoulder surgery in the BCP has become more common. Before and during surgery, a monitor placed on the patients forehead measures the amount of oxygen present in the brain to help control this to an acceptable level. A number of monitors are now commercially available. Two monitors are commonly discussed in the literature; the INVOS™ 5100 and the FORE-SIGHT® machines. However, the actual relationship between the supply of oxygen to the brain during surgery and the chance of later developing problems with memory and thinking (known as "post operative cognitive decline" - POCD) is not clear. It is also not known if one monitor is more accurate than another at predicting these complications.
Therefore, the main aim of this study is to examine the relationship between cerebral oxygen levels during shoulder surgery and the incidence of POCD (i.e. problems with memory and thinking). A second aim is to compare the INVOS™ 5100 and FORE-SIGHT® monitors ability to measure cerebral oxygen and cerebral desaturation events (CDEs) as well as the importance of other key clinical variables (e.g. blood pressure, nausea, body fat etc).
Study Overview
Detailed Description
PURPOSE OF THE INVESTIGATION The purpose of this investigation is to generate evidence about cerebral oxygenation during shoulder surgery and the incidence of POCD. Currently, evidence relating to POCD following surgery is conflicting and relates mostly to outcomes following cardiac surgery. There is a strong need to explore this relationship in the specific context of shoulder surgery in the BCP.
INTERVENTION GROUPS This study will involve a single prospective cohort. Patients who meet the selection criteria will be recruited to the study following voluntary informed consent . Cerebral oxygenation will be measured by application of cerebral oximeters to each patients forehead.
AIM OF THE STUDY This study has three aims; (i) To examine the relationship between cerebral desaturation during shoulder surgery in the BCP, and the incidence of POCD.
(ii) To determine the variation in cerebral oxygenation recorded using randomised (for superior/inferior) simultaneous application of the INVOS™ and FORE-SIGHT® oximeters, during shoulder surgery in the beach chair position.
(iii) Assess the relationships between cerebral oxygen desaturation during shoulder surgery in the BCP and variables including mean arterial pressure, incidence of nausea/vomiting, duration of hospital stay, BMI, hypertension and adverse events.
RESEARCH QUESTION There are three research questions correlating with the three research aims; (i) Is cerebral desaturation during shoulder surgery associated with POCD? (ii) Do the FORE-SIGHT® and INVOS™ 5100 devices vary in their measurement of cerebral oxygenation during shoulder surgery in the BCP? (iii) Is there a relationship between cerebral desaturation events during shoulder surgery in the BCP and variables including mean arterial blood pressure, post-operative nausea/vomiting, length of hospital stay, BMI, hypertension and any adverse events?
NULL HYPOTHESES The three null hypotheses are; (i) Cerebral desaturation as measured using cerebral oximetry is not related to POCD after shoulder surgery in the BCP.
(ii) There is no significant difference between the INVOS™ 5100 and the FORE-SIGHT® monitors assessment of cerebral oxygenation during shoulder surgery in the BCP.
(iii) There is no relationship between cerebral desaturation events during shoulder surgery in the BCP and variables including mean arterial blood pressure, the frequency of post-operative nausea/vomiting, length of hospital stay, BMI, hypertension and any adverse events.
PRIMARY HYPOTHESES The primary research hypotheses are; (i) Cerebral desaturation events during surgery in the BCP will be related to POCD.
(ii) The INVOS™ 5100 and the FORE-SIGHT® monitors will show no significant difference in their ability to measure cerebral oxygenation.
(iii) Cerebral desaturation events experienced during shoulder surgery in the BCP are related to a drop in mean arterial blood pressure, an increased likelihood of post-operative nausea and vomiting, greater length of hospital stay, a higher BMI, hypertension and greater frequency of adverse events.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Silvia Manzanero, PhD
- Phone Number: +61 7 3834 7069
- Email: researchmanager@upperlimb.com
Study Contact Backup
- Name: Mark Ross, MBBS
- Phone Number: +61 7 3834 6592
- Email: markross@upperlimb.com
Study Locations
-
-
Queensland
-
Brisbane, Queensland, Australia, 4000
- Recruiting
- Brisbane Hand and Upper Limb Research Institute, Brisbane Private Hospital
-
Contact:
- Silvia Manzanero, PhD
- Phone Number: +61 7 3834 7069
- Email: researchmanager@upperlimb.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Receiving treatment primarily by, but not restricted to, one of the Primary investigators for a shoulder condition that requires surgery in the BCP.
- Over 18 years of age
- Able to read and speak English
Exclusion Criteria:
- Under 18 years of age
- Pregnant women
- Pre-operative Mini-Mental State Examination (MMSE) < 24
- Pre-existing cerebrovascular disease as reported by the assessing medical consultant and recorded in patient charts
- Orthostatic hypotension
- American Society of Anaesthesiologists (ASA) physical status III, IV and V*
- History of drug and/or alcohol abuse
- Neurological disease (e.g. previous stroke)
- Significant mood and anxiety disorders as determined by treating consultant.
- Any other condition, which in the opinion of the investigators, would render the patient unsuitable for participation in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Surgery patients
Patients receiving shoulder surgery in the Beach Chair Position, and monitored by both INVOS and FORE-SIGHT monitors.
|
Monitored using both INVOS and FORE-SIGHT monitors.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Trail making test: Delis-Kaplan Executive Function System
Time Frame: Baseline
|
The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.
|
Baseline
|
Trail making test: Delis-Kaplan Executive Function System
Time Frame: 1 day post-operative
|
The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.
|
1 day post-operative
|
Trail making test: Delis-Kaplan Executive Function System
Time Frame: 8-14 days post-operative
|
The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.
|
8-14 days post-operative
|
Trail making test: Delis-Kaplan Executive Function System
Time Frame: 6 weeks post-operative
|
The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.
|
6 weeks post-operative
|
Trail making test: Delis-Kaplan Executive Function System
Time Frame: 3 months post-operative
|
The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.
|
3 months post-operative
|
Single letter verbal fluency
Time Frame: Baseline
|
This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.
|
Baseline
|
Single letter verbal fluency
Time Frame: 1 day post-operative
|
This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.
|
1 day post-operative
|
Single letter verbal fluency
Time Frame: 8-14 days post-operative
|
This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.
|
8-14 days post-operative
|
Single letter verbal fluency
Time Frame: 6 weeks post-operative
|
This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.
|
6 weeks post-operative
|
Single letter verbal fluency
Time Frame: 3 months post-operative
|
This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.
|
3 months post-operative
|
Rey Auditory Verbal Learning Test
Time Frame: Baseline
|
The RAVLT assesses immediate and delayed auditory memory recall and recognition.
The task consists of 15 nouns learned over 5 trials with a free recall after each presentation.
The order of presentation remaining fixed across trials (List A).
At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list.
Immediately after this, delayed recall of the first list is tested.
Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.
|
Baseline
|
Rey Auditory Verbal Learning Test
Time Frame: 1 day post-operative
|
The RAVLT assesses immediate and delayed auditory memory recall and recognition.
The task consists of 15 nouns learned over 5 trials with a free recall after each presentation.
The order of presentation remaining fixed across trials (List A).
At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list.
Immediately after this, delayed recall of the first list is tested.
Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.
|
1 day post-operative
|
Rey Auditory Verbal Learning Test
Time Frame: 8-14 days post-operative
|
The RAVLT assesses immediate and delayed auditory memory recall and recognition.
The task consists of 15 nouns learned over 5 trials with a free recall after each presentation.
The order of presentation remaining fixed across trials (List A).
At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list.
Immediately after this, delayed recall of the first list is tested.
Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.
|
8-14 days post-operative
|
Rey Auditory Verbal Learning Test
Time Frame: 6 weeks post-operative
|
The RAVLT assesses immediate and delayed auditory memory recall and recognition.
The task consists of 15 nouns learned over 5 trials with a free recall after each presentation.
The order of presentation remaining fixed across trials (List A).
At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list.
Immediately after this, delayed recall of the first list is tested.
Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.
|
6 weeks post-operative
|
Rey Auditory Verbal Learning Test
Time Frame: 3 months post-operative
|
The RAVLT assesses immediate and delayed auditory memory recall and recognition.
The task consists of 15 nouns learned over 5 trials with a free recall after each presentation.
The order of presentation remaining fixed across trials (List A).
At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list.
Immediately after this, delayed recall of the first list is tested.
Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.
|
3 months post-operative
|
Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)
Time Frame: Baseline
|
The examinee is verbally presented with a combination of numbers and letters or increasing amounts.
The examinee is required to recall the numbers in ascending order then letters in alphabetical order.
|
Baseline
|
Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)
Time Frame: 1 day post-operative
|
The examinee is verbally presented with a combination of numbers and letters or increasing amounts.
The examinee is required to recall the numbers in ascending order then letters in alphabetical order.
|
1 day post-operative
|
Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)
Time Frame: 8-14 days post-operative
|
The examinee is verbally presented with a combination of numbers and letters or increasing amounts.
The examinee is required to recall the numbers in ascending order then letters in alphabetical order.
|
8-14 days post-operative
|
Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)
Time Frame: 6 weeks post-operative
|
The examinee is verbally presented with a combination of numbers and letters or increasing amounts.
The examinee is required to recall the numbers in ascending order then letters in alphabetical order.
|
6 weeks post-operative
|
Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)
Time Frame: 3 months post-operative
|
The examinee is verbally presented with a combination of numbers and letters or increasing amounts.
The examinee is required to recall the numbers in ascending order then letters in alphabetical order.
|
3 months post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cerebral desaturation events (INVOS)
Time Frame: Intra-operative
|
Cerebral desaturation will be defined as a decrease in regional cerebral oxygen saturation greater than, or equal to 20% from baseline or a fall below 50% absolute.
|
Intra-operative
|
Cerebral desaturation events (FORE-SIGHT)
Time Frame: Intra-operative
|
Cerebral desaturation will be defined as a decrease in regional cerebral oxygen saturation greater than, or equal to 20% from baseline or a fall below 50% absolute.
|
Intra-operative
|
Mean arterial pressure
Time Frame: Intra-operative
|
Mean arterial blood pressure (mmHg)
|
Intra-operative
|
Body Mass Index
Time Frame: Baseline
|
Patient Body Mass Index (BMI)
|
Baseline
|
Hypertension
Time Frame: Baseline
|
Patient-reported hypertension
|
Baseline
|
Nausea and vomiting within 48 hours
Time Frame: 1 day, 8-14 days
|
Patient-reported nausea and vomiting
|
1 day, 8-14 days
|
Duration of hospital stay
Time Frame: 8-14 days
|
Patient duration of hospital stay
|
8-14 days
|
Adverse events
Time Frame: Intra-operative
|
Any adverse events arising during the trial will be closely monitored and followed up until the resolution of symptoms.
These will be checked at each assessment stage and recorded on a data collection form.
|
Intra-operative
|
Adverse events
Time Frame: 1 day
|
Any adverse events arising during the trial will be closely monitored and followed up until the resolution of symptoms.
These will be checked at each assessment
|
1 day
|
Adverse events
Time Frame: 8-14 days
|
Any adverse events arising during the trial will be closely monitored and followed up until the resolution of symptoms.
These will be checked at each assessment
|
8-14 days
|
Adverse events
Time Frame: 6 weeks
|
Any adverse events arising during the trial will be closely monitored and followed up until the resolution of symptoms.
These will be checked at each assessment
|
6 weeks
|
Adverse events
Time Frame: 3 months
|
Any adverse events arising during the trial will be closely monitored and followed up until the resolution of symptoms.
These will be checked at each assessment
|
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression Anxiety and Stress Scale-21
Time Frame: Baseline, 1 day, 8-14 days, 6 weeks, 3 months
|
The DASS-21 has 21 questions that index the level of depression, anxiety and stress an individual has experienced in the preceding week.
|
Baseline, 1 day, 8-14 days, 6 weeks, 3 months
|
Social Relationships and Support Scale
Time Frame: Baseline, 1 day, 8-14 days, 6 weeks, 3 months
|
The social support measures address the issues of social process in a range different clinical populations.
|
Baseline, 1 day, 8-14 days, 6 weeks, 3 months
|
Loneliness Scale
Time Frame: Baseline, 1 day, 8-14 days, 6 weeks, 3 months
|
A standardised 3-item Loneliness scale, comprised of items from the well-validated University of California, Los Angeles (UCLA) Loneliness scale.
|
Baseline, 1 day, 8-14 days, 6 weeks, 3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mark Ross, MBBS, Director
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ISR-2016-10757
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Dysfunction
-
Loma Linda UniversityCompleted1. Postoperative Cognitive DysfunctionUnited States
-
Mu Dong LiangNot yet recruitingPostoperative Cognitive Dysfunction(POCD)
-
HealthPartners InstituteCompletedPost Operative Cognitive DysfunctionUnited States
-
Burcu Ozalp HorsanaliCompletedPost Operative Cognitive Dysfunction
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingPOCD - Postoperative Cognitive DysfunctionChina
-
ImmunoChem Therapeutics, LLCNational Cancer Institute (NCI); Northwestern MedicineRecruitingCognitive Dysfunction, Cognitive DisorderUnited States
-
Xijing HospitalFirst Affiliated Hospital Xi'an Jiaotong University; Shanghai 10th People's... and other collaboratorsTerminatedPost Operative Cognitive DysfunctionChina
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)CompletedPost Operative Cognitive DysfunctionUnited States
-
Mayo ClinicCompletedCognitive Impairment | Mild Cognitive Impairment | Neurocognitive DysfunctionUnited States
-
Attikon HospitalCompleted
Clinical Trials on Dual-monitoring
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedPolycystic Ovary Syndrome
-
Biotronik FranceBiotronik SE & Co. KGCompletedTachycardia | DefibrillatorsFrance
-
Medical University of GrazCompletedHeart Failure | Osteoporosis | Osteoporotic Fractures | Pulse Wave Analysis | Blood Pressure Monitoring, Ambulatory | ComorbidityAustria
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Marmara UniversityCompletedDual Task Exercises in Elderly PeopleTurkey
-
Parc de Salut MarUnknownInspiratory Muscle TrainingSpain
-
VA Office of Research and DevelopmentRecruiting
-
University of Texas Southwestern Medical CenterAmerican Heart AssociationTerminatedHemorrhagic Stroke | HemiparesisUnited States
-
Arun RaoMedtronicCompletedSinus Node DysfunctionUnited States
-
ReShape LifesciencesUnknown